Echo takes first step toward gaining FDA OK for wireless glucose monitor

06/18/2013 | (Boston)

Echo Therapeutics has sent a presubmission package to the FDA for its wireless Symphony Continuous Glucose Monitoring System to be used in critical care settings. The move represents a significant first step toward the company's effort to bring the device to the U.S. market, CEO Patrick Mooney said.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN